Concerning liver-related primary cancers, NAM suppressed proliferation and enhanced apoptosis of HCC (hepatocellular carcinoma) in vitro mainly through stimulating the p53/p21 pathway [77]. The gene discussed is TP53; the disease is hepatocellular carcinoma.